Today (September 14) morning

Benli Technology Co., Ltd.

Listed and traded on the Growth Enterprise Market of the Shenzhen Stock Exchange

Became the 66th listed company in Taizhou

(The 61st company in total A shares)

Listing ceremony

The number of shares issued this time is 17.68 million shares, the issue price per share is 42.5 yuan, and the actual fundraising totals 751.4 million yuan; the stock abbreviation is "Benli Technology" and the stock code is "301065".

Benli Technology is located in Toumengang New District, Linhai City. It was established as a whole by Zhejiang Benli Chemical Co., Ltd. on July 3, 2015, with a registered capital of 70.68 million yuan (after the issuance) and 384 employees.

The company is mainly engaged in the R&D, production and sales of pharmaceutical intermediates, pesticide intermediates, and new material intermediates, and has a strong competitive advantage in the field of key intermediates for quinolone APIs. The company's product sales are mainly in the domestic market, supplemented by foreign markets, and have stable customer groups such as Jingxin Pharmaceutical, Zhejiang Guobang, India ADRG, and Japan AGC. The company is a high-tech enterprise with 10 invention patents. It has won the first prize of the Provincial Science and Technology Progress Award. It has established a good research and development cooperation relationship with Philip Chemicals, Hangzhou Normal University and other university scientific research institutions and other enterprises. In recent years, the company's operating performance has been stable. In 2019, 2020, and January-June 2021, the main business income was 559 million yuan, 625 million yuan and 329 million yuan, and net profits were 73 million yuan and 92 million yuan respectively. And 35 million yuan.